What is Immunome's invested capital?

Immunome (IMNM) reported invested capital of $9.69M in Q1 2026.

How has Immunome's invested capital changed year-over-year?

Immunome's invested capital decreased by 82.2% year-over-year, from $54.28M to $9.69M.

What is the long-term trend for Immunome's invested capital?

Over 4 years (2020 to 2025), Immunome's invested capital has grown at a 64.7% compound annual growth rate (CAGR), from $2.08M to -$15.28M.

What does invested capital mean?

Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).

Immunome IMNM Invested capital

Discontinued — last reported Q1 '26

Invested capital at other companies

Travel + LeisureTNL

18.8%+0.1pp

BeldenBDC

12.2%+0.5pp

Envista Holdings CorporationNVST

3.4%+1.8pp

Liberty Broadband CorporationLBRDK

-0.3%-0.1pp

Archer AviationACHR

-129.7%-62.3pp

Kiniksa Pharmaceuticals International, plcKNSA

17.5%+14.2pp

Other financials

Income statement

See full

Revenue--100%

Operating income-$59.3M-32.9%

Net income-$53.8M-29.3%

EPS (diluted)-$0.48+7.7%

Balance sheet

See full

Cash & equivalents$582.7M+126%

Total debt$3.7M-22.6%

Total equity$588.7M+91.7%

Total assets$619.8M+80.9%

Cash flow

See full

Operating cash flow-$58.6M-10.5%

CapEx$3.0M-18.1%

Free cash flow-$61.6M-8.7%

Valuation

See full

Market cap$2.19B+323%

Enterprise value$1.61B+470%

P/S545.2×+498×

Profitability

See full

Operating margin-5,947.9%-12,002pp

Net margin-5,593.8%-11,284pp

FCF margin-5,118.9%-8,601pp

Returns & leverage

See full

Return on equity-50.1%-10.8pp

Debt / equity0×0.0×

Current ratio21.7×+11.2×

Where this comes from

Calculated from Immunome’s reported figures.

$3.7Mtotal debt+$588.7Mtotal stockholders equity−$582.7Mcash and equivalents=$9.69M

The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunome's invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Immunome's invested capital?: Immunome (IMNM) reported invested capital of $9.69M in Q1 2026.
How has Immunome's invested capital changed year-over-year?: Immunome's invested capital decreased by 82.2% year-over-year, from $54.28M to $9.69M.
What is the long-term trend for Immunome's invested capital?: Over 4 years (2020 to 2025), Immunome's invested capital has grown at a 64.7% compound annual growth rate (CAGR), from $2.08M to -$15.28M.
What does invested capital mean?: Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).